Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Jaap J. Zwaginga; Bronno van der Holt; Peter A. te Boekhorst; Bart J. Biemond; Mark-David Levin; Rene van der Griend; Anneke Brand; Sonja Zweegman; Hans F. M. Pruijt; Vera M. J. Novotny; Art Vreugdenhil; Marco R. de Groot; Okke de Weerdt; Elisabeth C. M. van Pampus; Tanja M. van Maanen-Lamme; Shulamiet Wittebol; Martin R. Schipperus; Matthijs H. Silbermann; Peter C. Huijgens; Marleen Luten; Rene Hollestein; Jan A. C. Brakenhoff; Jolanda G. Schrama; Fransje A. A. Valster; Gerjo A. Velders; Harry R. Koene

doi:10.3324/haematol.2014.110213

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Jaap J. Zwaginga^*, Bronno van der Holt, Peter A. te Boekhorst, Bart J. Biemond, Mark-David Levin, Rene van der Griend, Anneke Brand, Sonja Zweegman, Hans F. M. Pruijt, Vera M. J. Novotny, Art Vreugdenhil, Marco R. de Groot, Okke de Weerdt, Elisabeth C. M. van Pampus, Tanja M. van Maanen-Lamme, Shulamiet Wittebol, Martin R. Schipperus, Matthijs H. Silbermann, Peter C. Huijgens, Marleen LutenRene Hollestein, Jan A. C. Brakenhoff, Jolanda G. Schrama, Fransje A. A. Valster, Gerjo A. Velders, Harry R. Koene

^*Corresponding author for this work

FHML non-thematic output

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	E90-E92
Journal	Haematologica-the Hematology Journal
Volume	100
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2014.110213
Publication status	Published - Mar 2015

Keywords

immune thrombocytopenia
rituximab
splenectomy delaying
early response
open label phase II

Access to Document

10.3324/haematol.2014.110213Licence: CC BY-NC

Cite this

Zwaginga, J. J., van der Holt, B., te Boekhorst, P. A., Biemond, B. J., Levin, M.-D., van der Griend, R., Brand, A., Zweegman, S., Pruijt, H. F. M., Novotny, V. M. J., Vreugdenhil, A., de Groot, M. R., de Weerdt, O., van Pampus, E. C. M., van Maanen-Lamme, T. M., Wittebol, S., Schipperus, M. R., Silbermann, M. H., Huijgens, P. C., ... Koene, H. R. (2015). Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients. Haematologica-the Hematology Journal, 100(3), E90-E92. https://doi.org/10.3324/haematol.2014.110213

@article{de23ef53800f4f0aaf0b29a85eda7d28,

title = "Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients",

keywords = "immune thrombocytopenia, rituximab, splenectomy delaying, early response, open label phase II",

author = "Zwaginga, {Jaap J.} and {van der Holt}, Bronno and {te Boekhorst}, {Peter A.} and Biemond, {Bart J.} and Mark-David Levin and {van der Griend}, Rene and Anneke Brand and Sonja Zweegman and Pruijt, {Hans F. M.} and Novotny, {Vera M. J.} and Art Vreugdenhil and {de Groot}, {Marco R.} and {de Weerdt}, Okke and {van Pampus}, {Elisabeth C. M.} and {van Maanen-Lamme}, {Tanja M.} and Shulamiet Wittebol and Schipperus, {Martin R.} and Silbermann, {Matthijs H.} and Huijgens, {Peter C.} and Marleen Luten and Rene Hollestein and Brakenhoff, {Jan A. C.} and Schrama, {Jolanda G.} and Valster, {Fransje A. A.} and Velders, {Gerjo A.} and Koene, {Harry R.}",

year = "2015",

month = mar,

doi = "10.3324/haematol.2014.110213",

language = "English",

volume = "100",

pages = "E90--E92",

journal = "Haematologica-the Hematology Journal",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

Zwaginga, JJ, van der Holt, B, te Boekhorst, PA, Biemond, BJ, Levin, M-D, van der Griend, R, Brand, A, Zweegman, S, Pruijt, HFM, Novotny, VMJ, Vreugdenhil, A, de Groot, MR, de Weerdt, O, van Pampus, ECM, van Maanen-Lamme, TM, Wittebol, S, Schipperus, MR, Silbermann, MH, Huijgens, PC, Luten, M, Hollestein, R, Brakenhoff, JAC, Schrama, JG, Valster, FAA, Velders, GA & Koene, HR 2015, 'Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients', Haematologica-the Hematology Journal, vol. 100, no. 3, pp. E90-E92. https://doi.org/10.3324/haematol.2014.110213

TY - JOUR

T1 - Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

AU - Zwaginga, Jaap J.

AU - van der Holt, Bronno

AU - te Boekhorst, Peter A.

AU - Biemond, Bart J.

AU - Levin, Mark-David

AU - van der Griend, Rene

AU - Brand, Anneke

AU - Zweegman, Sonja

AU - Pruijt, Hans F. M.

AU - Novotny, Vera M. J.

AU - Vreugdenhil, Art

AU - de Groot, Marco R.

AU - de Weerdt, Okke

AU - van Pampus, Elisabeth C. M.

AU - van Maanen-Lamme, Tanja M.

AU - Wittebol, Shulamiet

AU - Schipperus, Martin R.

AU - Silbermann, Matthijs H.

AU - Huijgens, Peter C.

AU - Luten, Marleen

AU - Hollestein, Rene

AU - Brakenhoff, Jan A. C.

AU - Schrama, Jolanda G.

AU - Valster, Fransje A. A.

AU - Velders, Gerjo A.

AU - Koene, Harry R.

PY - 2015/3

Y1 - 2015/3

KW - immune thrombocytopenia

KW - rituximab

KW - splenectomy delaying

KW - early response

KW - open label phase II

U2 - 10.3324/haematol.2014.110213

DO - 10.3324/haematol.2014.110213

M3 - Article

C2 - 25425692

SN - 0390-6078

VL - 100

SP - E90-E92

JO - Haematologica-the Hematology Journal

JF - Haematologica-the Hematology Journal

IS - 3

ER -